242 related articles for article (PubMed ID: 34415989)
1. Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer.
Redlich A; Luster M; Lorenz K; Lessel L; Rohrer TR; Schmid KW; Frühwald MC; Vorwerk P; Kuhlen M
J Clin Endocrinol Metab; 2022 Jan; 107(1):e165-e177. PubMed ID: 34415989
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for recurrence of differentiated thyroid carcinoma in children and adolescents: A retrospective cohort study.
Jia S; Tang D; Peng W
Medicine (Baltimore); 2023 Dec; 102(50):e36585. PubMed ID: 38115329
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
[TBL] [Abstract][Full Text] [Related]
5. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
[No Abstract] [Full Text] [Related]
6. Tumor size is an independent negative prognostic factor for event free survival in children with differentiated thyroid cancer.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Haqawi W; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2022; 13():979054. PubMed ID: 36093088
[TBL] [Abstract][Full Text] [Related]
7. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
9. Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.
Pires BP; Alves PA; Bordallo MA; Bulzico DA; Lopes FP; Farias T; Dias F; Lima RA; Santos Gisler IC; Coeli CM; Carvalhaes de Oliveira RV; Corbo R; Vaisman M; Vaisman F
Thyroid; 2016 Oct; 26(10):1480-1487. PubMed ID: 27540892
[TBL] [Abstract][Full Text] [Related]
10. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
[No Abstract] [Full Text] [Related]
11. Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers.
Majeed AK; Satapathy S; Ballal S; Bal C
J Clin Endocrinol Metab; 2023 May; 108(6):e208-e215. PubMed ID: 36577747
[TBL] [Abstract][Full Text] [Related]
12. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
13. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
[TBL] [Abstract][Full Text] [Related]
14. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
Maino F; Botte M; Dalmiglio C; Valerio L; Brilli L; Trimarchi A; Mattii E; Cartocci A; Castagna MG
J Clin Endocrinol Metab; 2024 Feb; 109(3):722-729. PubMed ID: 37804529
[TBL] [Abstract][Full Text] [Related]
16. Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
Zanella A; Scheffel RS; Pasa MW; Dora JM; Maia AL
Thyroid; 2017 Jun; 27(6):787-792. PubMed ID: 28292215
[TBL] [Abstract][Full Text] [Related]
17. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.
Sung TY; Jeon MJ; Lee YH; Lee YM; Kwon H; Yoon JH; Chung KW; Kim WG; Song DE; Hong SJ
J Clin Endocrinol Metab; 2017 Mar; 102(3):793-800. PubMed ID: 27809646
[TBL] [Abstract][Full Text] [Related]
18. Incomplete response to therapy in intermediate- and high-risk thyroid cancer.
Alzahrani AS; Mukhtar N
Endocrine; 2022 Dec; 78(3):531-542. PubMed ID: 36074242
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
20. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
